Sporos Bioventures
Overview
Sporos Bioventures is a private biopharmaceutical company that aims to transform the drug development process by focusing on key mechanisms and targets of disease to accelerate drug discovery research…
Investment Focus
- Late-stage drug development
- Biopharmaceutical innovation
- Medical device commercialization
- Addressing unmet medical needs
- Improving patient outcomes
- Collaborations with pharmaceutical, biotechnology, and medical technology companies
- Advancing critical path products to market
- Generating attractive, market-unrelated returns at lower risk
- Funding late-stage development of innovative core products
- Capturing value directly from funded products
- Maintaining a high success rate in clinical trials
- Supporting the development of novel medicines in immunology and inflammation
- Providing strategic funding and operational expertise
- Accelerating the development and commercialization of innovative therapies
- Operating globally across multiple therapeutic areas
- Managing substantial assets under management
- Launching and supporting clinical-stage drug development companies
- Investing in companies with significant unmet medical needs
- Advancing therapies with potential to improve patient outcomes
- Maintaining a strong track record in the life sciences sector
Portfolio Companies
Reach Sporos Bioventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Sporos Bioventures
What sectors does Sporos Bioventures invest in?
Sporos Bioventures invests in Healthcare, Healthcare Services, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Houston, United States. Sporos Bioventures is listed as a private equity in the ConnectSafely investor database.
What stage does Sporos Bioventures invest at?
Sporos Bioventures backs companies at Growth, Late Stage and Pre-IPO, writing cheques of 50M - 1B.
Which regions does Sporos Bioventures invest in?
Sporos Bioventures invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
Who are the partners at Sporos Bioventures?
Team members listed for Sporos Bioventures include Joseph Kekst (Co-Founder, Partner) and Ryan Thompson (Chief Executive Officer).
What companies has Sporos Bioventures invested in?
Sporos Bioventures's portfolio includes Moderna, Alnylam Pharmaceuticals, Anthos Therapeutics, Inc. and Uniquity Bio.
How do I contact Sporos Bioventures?
Sporos Bioventures's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
